287 results on '"Vukovic V"'
Search Results
2. A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)
3. Determinants of intention to work abroad of college and specialist nursing graduates in Serbia
4. ALRN 6924 induces cell cycle arrest in bone marrow stem cells and hair follicles with dose-dependent degree and duration of effects after a single infusion in healthy volunteers
5. Survival, recurrence and second primary malignancies in HNC cancer: a multicentre study: Roberta Pastorino
6. Identifying elderly with low vaccine uptake using social deprivation indices: a systematic review: Vladimir Vukovic
7. A rush to explore protein–ligand electrostatic interaction energy with Charger
8. PB2162: INCREASED OXIDATIVE STRESS IN DIFFUSE LARGE B-CELL LYMPHOMA
9. PB2141: CLINICOPATHOLOGICAL FEATURES AND OUTCOME OF CD5 POSITIVE DIFFUSE LARGE B CELL LYMPHOMA AND THE SIGNIFICANCE OF CD5 EXPRESSION STRENGTH: 10-YEAR SINGLE CENTER EXPERIENCE
10. P1694: THROMBOSIS RISK ASSESSMENT IN LYMPHOMA PATIENTS - PROSPECTIVE PILOT SUDY
11. PB2086: CHRONIC LYMPHOPROLIFERATIVE DISORDER OF NK CELLS WITH LIVER INFILTRATION
12. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
13. Thrombotic and bleeding complications in patients with chronic lymphocytic leukemia and severe COVID-19: a study of ERIC, the European Research Initiative on CLL
14. Knowledge of Healthcare Workers Regarding Road Traffic Child Safety in South Bačka District, Serbia
15. Lipidomics, Atrial Conduction, and Body Mass Index: Evidence From Association, Mediation, and Mendelian Randomization Models
16. Italian contribution to University Autonomy in Kazakhstan: the Erasmus+ project “Transition to University Autonomy in Kazakhstan” (TRUNAK)
17. 1791P A phase I pharmacology study of the dual MDMX/MDM2 inhibitor, ALRN 6924, in healthy volunteers
18. 1654P A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression
19. Review of heat demand time series generation for energy system modelling
20. Unique presentation of T-cell/histiocyte-rich large B cell lymphoma complicated with hemophagocytic lymphohistiocytosis: Case report and review of the literature
21. Blockchain in supply chain management in automotive industry: Systematic literature review
22. ULTRASONOGRAPHY OF THE OPTIC NERVE SHEATH IN BRAIN DEATH: P72
23. Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924
24. Distinguishing Parkinsonʼs disease and essential tremor with transcranial sonography
25. When politicians collude with firms: the impact of elite networks on inequality
26. The International Conference on Energy and Sustainable Futures (ICESF): Nottingham Trent University, Nottingham, 9 to 11 September 2019
27. 136 (PB126) - ALRN 6924 induces cell cycle arrest in bone marrow stem cells and hair follicles with dose-dependent degree and duration of effects after a single infusion in healthy volunteers
28. Analysis of influenza vaccination coverage among the elderly living in Rome, based on a deprivation index, 2009-2013
29. A phase IIa clinical trial combining ALRN-6924 and palbociclib for the treatment of patients with tumours harboring wild-type p53 and MDM2 amplification or MDM2/CDK4 co-amplification
30. PB2278 PRETREATMENT SERUM 25(OH) VITAMIN D AS PREDICTOR OF EVENT- FREE SURVIVAL IN LYMPHOID MALIGNANCIES
31. PB1902 THE BARCELONA-BRNO BIOMARKERS-ONLY PROGNOSTIC MODEL FOR CHRONIC LYMPHOCYTIC LEUKEMIA - SINGLE CENTRE EXPERIENCE
32. S1645 NEUTROPHIL TO LYMPHOCYTE RATIO, PLATELET TO LYMPHOCYTE RATIO, AND RISK OF THROMBOEMBOLISM IN PATIENTS WITH LYMPHOMA RECEIVING CHEMOTHERAPY
33. NEUTROPHIL TO LYMPHOCYTE RATIO, PLATELET TO LYMPHOCYTE RATIO, AND RISK OF THROMBOEMBOLISM IN PATIENTS WITH LYMPHOMA RECEIVING CHEMOTHERAPY
34. PB1908 THE SIGNIFICANCE OF THE INTERNATIONAL PROGNOSTIC INDEX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL-IPI) IN SERBIAN CLL PATIENTS
35. HEALTH TECHNOLOGY ASSESSMENT EVIDENCE on E-HEALTH/M-HEALTH TECHNOLOGIES: EVALUATING the TRANSPARENCY and THOROUGHNESS
36. HTA applicato alla pianificazione, alla programmazione e all'organizzazione sanitaria
37. INDICI DI DEPRIVAZIONE SOCIO-ECONOMICO SANITARI E STATO DI SALUTE DEGLI OVER65: PRIMI RISULTATI
38. Does public reporting influence quality, patient and provider's perspective, market share and disparities? A review
39. CHRONIC LYMPHOCYTIC LEUKEMIA INVOLVEMENT OF CENTRAL NERVOUS SYSTEM: A SINGLE CENTRE EXPERIENCE
40. COMPARATIVE ANALYSIS OF PREDICTIVE MODELS FOR THROMBOEMBOLIC EVENTS IN LYMPHOMA PATIENTS
41. Achievement of complete remission after autologous stem cell transplantation is strongly corelated with improved survival of patients with Hodgkin lymphoma
42. Pitfalls of positivity–new perspectives on the futility of negating negativity
43. P-051: Thrombosis lymphoma score performance in female population
44. Clinical features and prognostic factors in patients with head and neck cancer – Results from a multicentric study
45. 475P - A phase IIa clinical trial combining ALRN-6924 and palbociclib for the treatment of patients with tumours harboring wild-type p53 and MDM2 amplification or MDM2/CDK4 co-amplification
46. Development of acid-labile immunoconjugates for tumor-specific activation of cytotoxins
47. Changes in Quality, Market Share and Disparities after Performance Publication: A Systematic Review
48. Assessing health technologies through the HTA approach: the basic methodology to be used
49. The HTA evidence on e-health/m-health: which challenges?
50. Economic impact of schizophrenia on health systems
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.